dtSearch adds variety of updates to its search portfolio
dtSearch is releasing version 2025.02 of its enterprise and developer product line for instantly searching terabytes of online…
GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications
Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust NASHVILLE, Tenn., December 4, 2025 (Newswire.com)…
Roche’s Potential Blockbuster Fuels Best Month Since 1997
Roche Holding AG’s shares just posted their best month since 1997, lifted by optimism over an experimental breast…
Lilly, Novo to Lower Obesity Drug Prices in Deal with Trump
Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for…
This Open Enrollment Season Employers Are Passing More Costs on to Workers
Americans embarking on the annual task of sifting through the health plans offered by their employers to find…
Johnson & Johnson faces UK lawsuit over talc cancer claim
The company “chose to keep it on the market in the pursuit of profit”, it added, claiming J&J…
Can Huntington’s Disease Be Cured? A New Breakthrough Gene Therapy Offers Hope
Hi, this is Naomi in Berlin. Today I’m looking west to Scotland, where the possibility of a treatment…
Ozempic-Maker Novo Stops Work on Cell Therapy Cure for Type 1 Diabetes
Novo Nordisk A/S cut its cell therapy division, which has been trying to find a cure for type…
Pfizer’s Deal on Drug Prices Is Good But Deserves Scrutiny
American taxpayers spend billions of dollars annually supporting pharmaceutical development. Yet the US continues to pay more for…
Novo (NVO) Plans to Make Obesity Pill Available Online Once Approved
Novo Nordisk A/S plans to launch its new obesity pill on telehealth sites like Ro and WeightWatchers as…
Pfizer to Cut Some Drug Prices in Deal With President Trump
Pfizer Inc. will announce plans to lower prescription drug prices at an event Tuesday alongside President Donald Trump,…
Pharma Middlemen Seek to Head Off New Rules With Voluntary Changes
Pharmacy middlemen are working on a proposal to voluntarily change some of their business practices in an effort…